Posted 5 years ago (0 comments)
The Patient Recruiting Agency™ announces the recruitment for a medical research study of individuals with thyroid eye disease associated with Graves’ disease (also called Graves’ orbitopathy).
This research study will involve 84 patients with thyroid eye disease across approximately 20 study centers in the United States. Study participants must be 18 to 75 years of age and must have had symptoms of thyroid eye disease for fewer than six months. To qualify, participants must have not yet received any treatment for their eye symptoms other than lubricating eye drops. The purpose of this research study is to evaluate the efficacy, safety and tolerability of an investigational medication that may help to alleviate the symptoms of thyroid eye disease.
For more information about the research study, please visit http://www.graveseyediseasestudy.com/?prsid=47&praid=1&prtid=1.
IMPORTANT NOTE: The above website will close on Feb. 28, 2014. After that date, please visit clinicaltrials.gov and search for trial # NCT01868997 for information on patient recruiting. (You can enter this # in the search box on the left-hand side of the screen).